Behrenbruch Christian (CIK 2037713) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-06). Recent activity: Buy TLX (34,500 shares), Buy TLX (33,435 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-06 | Telix Pharmaceuticals Ltd (TLX) | MD & Group CEO | Buy | 34,500 | $499,560 |
| 2026-05-06 | Telix Pharmaceuticals Ltd (TLX) | MD & Group CEO | Buy | 33,435 | $497,178 |
Source: SEC Form 4 filings · as of 2026-05-06